impact factor, citescore
logo
 

shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER8652Infliximab is the new kid on the block in Kawasaki disease: a single-centre study over 8 years from North India20.00 €
 Subtotal 20.00 €